CDMRP announced research funding opportunities for fiscal year 2022. CDMRP aim to fund high-risk, high-gain, high-impact projects which other funding agencies may overlook and thus to fill research gaps in critical areas. The FreeMind Group hosted a webinar about these new opportunities. Get the recording, slides, and critical forms here.
Tag Archive for: CDMRP
The Congressionally Directed Medical Research Programs (CDMRP) have announced their research funding opportunities for fiscal year 2022. Here’s an overview of the ALS funding opportunities. Learn more about these awards and others in our upcoming webinar, Wednesday, March 30, 2022, 1 PM (Eastern).
The Congressionally Directed Medical Research Programs (CDMRP) have announced their research funding opportunities for fiscal year 2022. Here’s an overview of the breast cancer research funding opportunities. Learn more about these awards and others in our upcoming webinar, Wednesday, March 30, 2022, 1 PM (Eastern).
Dr. Sarah Fontaine discusses CDMRP non-dilutive funding opportunities for neuroscience R&D.
Dr. Donna Kimbark discusses CDMRP’s unique non-dilutive funding opportunities for cancer R&D.
The Congressionally Directed Medical Research Programs (CDMRP), are supported by funds allocated by Congress for biomedical research in response to the needs of the American people and military. With a FY2018 budget of over $975 million, these funds will go towards supporting R&D efforts in various stages of development. Some research areas covered include Breast Cancer, Parkinson’s, and Multiple Sclerosis as well as additional Peer Reviewed topics covering Alzheimer’s, Cancer, and others.
In this webinar, we discuss the various programs, the process for applying, guidelines, key success components and insight into increasing chances for award.
NIH alone awards roughly $6B annually to Cancer related R&D grants and contracts. The scope of funding support covers much of the R&D cycle, from basic research, through pre-clinical activities and early phase clinical trials.
In this webinar, we discuss key cancer related opportunities, focusing on the new set of solicitations from the National Cancer Institute (NCI) and the soon to be released CDMRPs (DoD) that are available for life science organizations.
Website Links
Address
FreeMind Group
6 Liberty Square #2783
Boston, MA 02109